Log in to save to my catalogue

A randomized open label trial of tamoxifen combined with amphotericin B and fluconazole for cryptoco...

A randomized open label trial of tamoxifen combined with amphotericin B and fluconazole for cryptoco...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0268824a27364ad5af1686a9a5db3b01

A randomized open label trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis

About this item

Full title

A randomized open label trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis

Publisher

England: Wellcome Trust Limited

Journal title

Wellcome open research, 2019, Vol.4, p.8

Language

English

Formats

Publication information

Publisher

England: Wellcome Trust Limited

More information

Scope and Contents

Contents

Background
: Cryptococcal meningitis is a leading cause of death in HIV-infected patients. International treatment guidelines recommend induction therapy with amphotericin B and flucytosine. This antifungal combination is most effective, but unfortunately flucytosine is expensive and unavailable where the burden of disease is greatest. Where una...

Alternative Titles

Full title

A randomized open label trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_0268824a27364ad5af1686a9a5db3b01

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0268824a27364ad5af1686a9a5db3b01

Other Identifiers

ISSN

2398-502X

E-ISSN

2398-502X

DOI

10.12688/wellcomeopenres.15010.1

How to access this item